Filgrastim (rhG-CSF) Injection is an essential pharmaceutical product, utilized for treating conditions associated with white blood cell production. This product is a recombinant form of a naturally occurring protein, granulocyte colony-stimulating factor (G-CSF). Major features include:
Potential users must consult with a healthcare professional prior to use.
Filgrastim, also known by its chemical name Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF), comes in a sterile injection form. This pharmaceutical-grade product is a potent therapeutic agent, primarily used as a treatment for patients with low white blood cell count (neutropenia) due to cancer treatments. Filgrastim works by stimulating the bone marrow to produce more neutrophils, which are vital for fighting off infections.
Filgrastim is prescribed for:
While Filgrastim could help patients recover from neutropenia, certain precautions need to be observed:
Please consult with your healthcare provider for dosage and side effects details, and any potential interactions with other medications.